1-7 of 7
Geoffrey A. Block
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Trial of the Impact of Ferric Citrate on Erythropoietin and Intravenous Iron Use in Patients Receiving Dialysis

Subject Area:
Nephrology
Geoffrey A. Block, Mohammed Reza Mizani, Varshasb Broumand, F. David Newby, Ayodele Erinle, Carolina Arias, Martha Block, Stephanie Brillhart, Amanda Leppink, Mark Danese, Mary Dittrich
Journal: American Journal of Nephrology
Am J Nephrol (2024) 55 (5): 520–528.
https://doi.org/10.1159/000540227
Published Online: 15 July 2024
View article titled, A Randomized Trial of the Impact of Ferric Citrate on Erythropoietin and Intravenous Iron Use in Patients Receiving Dialysis
Open the PDF for A Randomized Trial of the Impact of Ferric Citrate on Erythropoietin and Intravenous Iron Use in Patients Receiving Dialysis in another window
Journal Articles

Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome

Subject Area:
Nephrology
Glenn M. Chertow, Gerald B. Appel, Sharon Andreoli, Sripal Bangalore, Geoffrey A. Block, Arlene B. Chapman, Melanie P. Chin, Keisha L. Gibson, Angie Goldsberry, Kazumoto Iijima, Lesley A. Inker, Bertrand Knebelmann, Laura H. Mariani, Colin J. Meyer, Kandai Nozu, Megan O’Grady, Arnold L. Silva, Peter Stenvinkel, Roser Torra, Bradley A. Warady, Pablo E. Pergola
Journal: American Journal of Nephrology
Am J Nephrol (2021) 52 (3): 180–189.
https://doi.org/10.1159/000513777
Published Online: 31 March 2021
View article titled, Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome
Open the PDF for Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome in another window
Journal Articles

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

Subject Area:
Nephrology
Melanie P. Chin, George L. Bakris, Geoffrey A. Block, Glenn M. Chertow, Angie Goldsberry, Lesley A. Inker, Hiddo J.L. Heerspink, Megan O’Grady, Pablo E. Pergola, Christoph Wanner, David G. Warnock, Colin J. Meyer
Journal: American Journal of Nephrology
Am J Nephrol (2018) 47 (1): 40–47.
https://doi.org/10.1159/000486398
Published Online: 18 January 2018
View article titled, Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
Open the PDF for Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study in another window
Journal Articles

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

Subject Area:
Nephrology
Francesco Locatelli, Steven Fishbane, Geoffrey A. Block, Iain C. Macdougall
Journal: American Journal of Nephrology
Am J Nephrol (2017) 45 (3): 187–199.
https://doi.org/10.1159/000455166
Published Online: 25 January 2017
View article titled, Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Open the PDF for Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients in another window
Journal Articles

Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis

Subject Area:
Nephrology
David A. Bushinsky, Patrick Rossignol, David M. Spiegel, Wade W. Benton, Jinwei Yuan, Geoffrey A. Block, Christopher S. Wilcox, Rajiv Agarwal
Journal: American Journal of Nephrology
Am J Nephrol (2016) 44 (5): 404–410.
https://doi.org/10.1159/000451067
Published Online: 27 October 2016
View article titled, Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis
Open the PDF for Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis in another window
Journal Articles

Treatment of Secondary Hyperparathyroidism: Results of a Phase 2 Trial Evaluating an Intravenous Peptide Agonist of the Calcium-Sensing Receptor

Subject Area:
Topic Article Package: Pharmacology 2016 , Nephrology
David A. Bushinsky, Geoffrey A. Block, Kevin J. Martin, Gregory Bell, Saling Huang, Yan Sun, David M. Spiegel, Liron Walsh, T. Christian Mix, Reshma Kewalramani
Journal: American Journal of Nephrology
Am J Nephrol (2016) 42 (5): 379–388.
https://doi.org/10.1159/000442754
Published Online: 19 December 2015
View article titled, Treatment of Secondary Hyperparathyroidism: Results of a Phase 2 Trial Evaluating an Intravenous Peptide Agonist of the Calcium-Sensing Receptor
Open the PDF for Treatment of Secondary Hyperparathyroidism: Results of a Phase 2 Trial Evaluating an Intravenous Peptide Agonist of the Calcium-Sensing Receptor in another window
Journal Articles

Increasing Hip Fractures in Patients Receiving Hemodialysis and Peritoneal Dialysis

Subject Area:
Nephrology
Anna T. Mathew, Azzour Hazzan, Kenar D. Jhaveri, Geoffrey A. Block, Shailaja Chidella, Lisa Rosen, John Wagner, Steve Fishbane
Journal: American Journal of Nephrology
Am J Nephrol (2014) 40 (5): 451–457.
https://doi.org/10.1159/000369039
Published Online: 26 November 2014
View article titled, Increasing Hip Fractures in Patients Receiving Hemodialysis and Peritoneal Dialysis
Open the PDF for Increasing Hip Fractures in Patients Receiving Hemodialysis and Peritoneal Dialysis in another window